StockVS

Acadia Healthcare Company, Inc. (ACHC) 주식 분석

의료

Acadia Healthcare Company, Inc.

$23.49

+$0.31 (+1.34%)

최종 업데이트: 2026년 5월 26일

가격 추이

분석

회사 개요

Acadia Healthcare Company, Inc. operates within the healthcare sector, specifically focusing on the medical care facilities industry by providing behavioral healthcare services across the United States and Puerto Rico. The company's core business model involves owning and operating acute inpatient psychiatric facilities, along with specialty treatment centers that include residential recovery facilities and eating disorder treatment programs. In terms of scale, Acadia Healthcare Company, Inc. holds a market capitalization of $2.51 billion and generates annual revenue of $3.31 billion, supported by a workforce of 19,000 employees. These valuation and revenue figures indicate that the company maintains a significant presence in the behavioral health landscape, serving as a major provider for inpatient psychiatric and specialized recovery care services.

재무 건전성

The company reported a revenue of $3.31 billion for the trailing twelve months, while recording a net income of -$1,102,771,968 and an EBITDA of $577.21 million. The substantial gap between the positive revenue and the negative net income reveals a heavy cost structure where operating expenses and interest costs significantly erode bottom-line profitability, resulting in a loss despite positive operational earnings before interest and taxes. Free cash flow stands at -$370,052,864, which indicates that the company is currently consuming cash to fund its operations and capital expenditures, thereby limiting its immediate financial flexibility for external expansion or debt reduction. The gross margin is 41.5%, suggesting a moderate ability to control direct costs relative to revenue, while the operating margin of 5.8% reflects tighter control over overhead expenses compared to gross profitability. However, the profit margin of -33.3% highlights the severe impact of fixed costs and interest obligations on the final earnings per dollar of revenue. On the balance sheet, the company holds $133.24 million in cash against a total debt load of $2.65 billion, resulting in a debt-to-equity ratio of 124.03, which signifies a highly leveraged financial position rather than a conservative one. The current ratio is 1.55, indicating that the company possesses sufficient current assets to cover its short-term liabilities with a margin of safety. Return on equity is -41.0%, showing that shareholders are currently experiencing losses, while the return on assets stands at 4.2%, suggesting that the asset base is generating some positive operational returns before financing costs are deducted.

밸류에이션 평가

The trailing twelve-month P/E ratio is listed as N/A due to the negative earnings, whereas the forward P/E is 16.23, implying that the market is pricing in expected future earnings growth to offset current losses. The price-to-book ratio is 1.26, which indicates that the market values the company's equity at a slight premium relative to its book value, despite the current negative net income. Alternative valuation metrics such as the price-to-sales ratio of 0.76 and an EV/EBITDA of 9.05 suggest that the stock is priced conservatively relative to its sales and operational earnings power. The 52-week high is $30.17 and the 52-week low is $11.43, placing the current trading range within a wide band of volatility where the price has recovered significantly from the low but remains below the peak. The beta of 0.71 indicates that the stock's price volatility is lower than that of the broader market, suggesting it may act as a defensive holding relative to the overall equity index.

Growth & Income

Revenue growth year-over-year is 6.1%, while earnings growth is N/A due to the reported net loss, meaning that revenue expansion has not yet translated into profitability improvement. As a non-dividend payer, the company does not distribute dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the company retains all earnings and cash flow to reinvest into its facility network or service offerings. Since there is no dividend income to analyze for sustainability, the focus shifts entirely to the company's ability to utilize its retained earnings to drive future operational efficiency and potentially reverse the negative net income trend. The overall growth and income profile is characterized by steady revenue expansion without current earnings growth or dividend income, relying on capital appreciation and operational turnaround for shareholder value.

동종업체 비교

Acadia Healthcare Company, Inc. (ACHC) 은(는) 의료 시설 산업에서 운영됩니다. 시가총액 기준으로 가장 가까운 동종업체와의 비교는 다음과 같습니다:

기업명 티커 시가총액 PER
Acadia Healthcare Company, Inc. ACHC $2.16B N/A
HCA Healthcare, Inc. HCA $87.05B 13.5
Tenet Healthcare Corporation THC $15.19B 9.2
DaVita Inc. DVA $12.55B 18.8

의료 시설 산업 평균 PER은 28.6배입니다. Acadia Healthcare Company, Inc.의 PER은 N/A입니다.

이 분석은 AI가 생성한 것으로 정보 제공 목적으로만 사용되며 투자 조언이 아닙니다. 데이터가 지연되거나 부정확할 수 있습니다. 투자 결정을 내리기 전에 항상 직접 조사하고 자격을 갖춘 재무 상담사와 상담하세요.

Acadia Healthcare Company, Inc. 소개

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

회사 설명은 영어로 표시됩니다.

웹사이트 방문 →

주요 지표

시가총액
$2.16B
PER
N/A
52주 최고가
$30.20
52주 최저가
$11.43
평균 거래량
3.05M
베타
0.73

데이터는 yfinance를 통해 Yahoo Finance에서 제공됩니다. 매일 업데이트.

기업 정보

거래소
NASDAQ
국가
United States
직원 수
25,000